4.3 Article

ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H+K+ATPase alpha subunit

Journal

APMIS
Volume 124, Issue 7, Pages 561-566

Publisher

WILEY
DOI: 10.1111/apm.12546

Keywords

Gastric proton pump; carcinoids; neuroendocrine tumour; gastrin; proton pump inhibitors

Funding

  1. Liaison Committee

Ask authors/readers for more resources

A family with a missense variant of the ATP4A gene encoding the alpha subunit of the gastric proton pump (H(+)K(+)ATPase) has recently been described. Homozygous siblings were hypergastrinemic (median gastrin 486 pM) and had gastric tumours diagnosed at a median age of 33 years. In the current histopathological study, we further characterized the tumours found in the gastric corpus. The tumours had the histological appearance of carcinoids (NET G1 or G2) and were immunoreactive for the general neuroendocrine markers chromogranin A (CgA) and synaptophysin as well as the ECL-cell markers vesicular monoamine transporter 2 (VMAT2) and histidine decarbozylase (HDC). One of the tumours consisted of a NET G2 component, but also had a component with glandular growth, which morphologically was classified as an intestinal type adenocarcinoma. Many glands of the adenocarcinoma contained a large proportion of cells positive for neuroendocrine markers, especially the small vesicle marker synaptophysin and the cytoplasmic enzyme HDC. In conclusion, patients homozygous for an inactivating ATP4A mutation develop gastric ECL-cell carcinoids in their 3rd or 4th decade. The adenocarcinoma may be classified as neuroendocrine with ECL-cell differentiation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available